NEW YORK, Aug. 28 – Entropia, of San Diego, on Tuesday said that Swiss pharmaceutical company Novartis will evaluate its PC-based distributed computing technology under a two-month pilot study.

Under the program, Novartis, with headquarters in Basel, will assess the ability of the technology—which harnesses spare cycles available from an existing network of PCs—to meet the computational demands of its drug-discovery efforts.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.